Cargando…

Association between Oxidative Burden and Restenosis: A Case-Control Study

BACKGROUND: In-stent restenosis (ISR) is an important clinical complication that occurs following stent implantation. The application of drug-eluting stents (DES) and even consumption of drugs such as antiplatelet agents and statins are not completely effective in reducing ISR risk. Since the number...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganjali, Shiva, Mansouri, Atena, Abbasifard, Mitra, Moallem, Seyed Adel, Tayarani-Najaran, Zahra, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256427/
https://www.ncbi.nlm.nih.gov/pubmed/35799893
http://dx.doi.org/10.1155/2022/3577761
_version_ 1784741111067049984
author Ganjali, Shiva
Mansouri, Atena
Abbasifard, Mitra
Moallem, Seyed Adel
Tayarani-Najaran, Zahra
Sahebkar, Amirhossein
author_facet Ganjali, Shiva
Mansouri, Atena
Abbasifard, Mitra
Moallem, Seyed Adel
Tayarani-Najaran, Zahra
Sahebkar, Amirhossein
author_sort Ganjali, Shiva
collection PubMed
description BACKGROUND: In-stent restenosis (ISR) is an important clinical complication that occurs following stent implantation. The application of drug-eluting stents (DES) and even consumption of drugs such as antiplatelet agents and statins are not completely effective in reducing ISR risk. Since the number of these patients continues to rise, it is pivotal to detect patients who are at a higher risk of ISR. In addition, identification of biochemical markers of ISR could give the right perspective on choosing the proper strategy to treat these patients. Several pathophysiological pathways including oxidative stress (OS) are implicated in the progression of ISR. Hence, this study aimed to evaluate the association between oxidative/anti-oxidative markers and ISR. METHODS: This was a case-control study which comprised 21 ISR, 26 NISR (non-ISR), and 20 healthy subjects. The serum levels of OS markers including malondialdehyde (MDA), thiol groups (GSH), total antioxidant capacity (TAC), and the activity of serum antioxidant enzymes such as glutathione peroxidase (GPx) and superoxide dismutase (SOD) were assessed by colorimetric methods. The overall oxidative burden was assessed using a pro-oxidant-antioxidant balance (PAB) assay. RESULTS: MDA levels were considerably higher in the ISR group when compared to healthy subjects (P = 0.004). PAB also indicated significantly higher values in both ISR (P < 0.001) and NISR (P < 0.001) groups related to healthy subjects. No significant differences were observed between the studied groups regarding thiol levels, antioxidant enzyme activities, and TAC. Multinomial logistic regression analysis showed that elevated serum levels of MDA (OR: 1.028, 95% CI: 1.008-1.048; P = 0.006) and PAB (OR: 1.076, 95% CI: 1.017-1.139; P = 0.011) were significantly associated with higher ISR risk; however, increased values of TAC (OR: 0.990, 95% CI: 0.982-0.999; P = 0.030) were significantly associated with decreased ISR risk, while after adjustment for confounders, only SOD activity (OR: 0.0, 95% CI: 0.0-0.0; P < 0.001) and PAB value (OR: 1.866, 95% CI: 1.856-1.900; P < 0.001) showed association with ISR risk. CONCLUSION: According to the present findings, some oxidative and antioxidative markers like PAB and SOD activity showed the potential in the prediction of ISR risk.
format Online
Article
Text
id pubmed-9256427
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92564272022-07-06 Association between Oxidative Burden and Restenosis: A Case-Control Study Ganjali, Shiva Mansouri, Atena Abbasifard, Mitra Moallem, Seyed Adel Tayarani-Najaran, Zahra Sahebkar, Amirhossein Oxid Med Cell Longev Research Article BACKGROUND: In-stent restenosis (ISR) is an important clinical complication that occurs following stent implantation. The application of drug-eluting stents (DES) and even consumption of drugs such as antiplatelet agents and statins are not completely effective in reducing ISR risk. Since the number of these patients continues to rise, it is pivotal to detect patients who are at a higher risk of ISR. In addition, identification of biochemical markers of ISR could give the right perspective on choosing the proper strategy to treat these patients. Several pathophysiological pathways including oxidative stress (OS) are implicated in the progression of ISR. Hence, this study aimed to evaluate the association between oxidative/anti-oxidative markers and ISR. METHODS: This was a case-control study which comprised 21 ISR, 26 NISR (non-ISR), and 20 healthy subjects. The serum levels of OS markers including malondialdehyde (MDA), thiol groups (GSH), total antioxidant capacity (TAC), and the activity of serum antioxidant enzymes such as glutathione peroxidase (GPx) and superoxide dismutase (SOD) were assessed by colorimetric methods. The overall oxidative burden was assessed using a pro-oxidant-antioxidant balance (PAB) assay. RESULTS: MDA levels were considerably higher in the ISR group when compared to healthy subjects (P = 0.004). PAB also indicated significantly higher values in both ISR (P < 0.001) and NISR (P < 0.001) groups related to healthy subjects. No significant differences were observed between the studied groups regarding thiol levels, antioxidant enzyme activities, and TAC. Multinomial logistic regression analysis showed that elevated serum levels of MDA (OR: 1.028, 95% CI: 1.008-1.048; P = 0.006) and PAB (OR: 1.076, 95% CI: 1.017-1.139; P = 0.011) were significantly associated with higher ISR risk; however, increased values of TAC (OR: 0.990, 95% CI: 0.982-0.999; P = 0.030) were significantly associated with decreased ISR risk, while after adjustment for confounders, only SOD activity (OR: 0.0, 95% CI: 0.0-0.0; P < 0.001) and PAB value (OR: 1.866, 95% CI: 1.856-1.900; P < 0.001) showed association with ISR risk. CONCLUSION: According to the present findings, some oxidative and antioxidative markers like PAB and SOD activity showed the potential in the prediction of ISR risk. Hindawi 2022-06-28 /pmc/articles/PMC9256427/ /pubmed/35799893 http://dx.doi.org/10.1155/2022/3577761 Text en Copyright © 2022 Shiva Ganjali et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ganjali, Shiva
Mansouri, Atena
Abbasifard, Mitra
Moallem, Seyed Adel
Tayarani-Najaran, Zahra
Sahebkar, Amirhossein
Association between Oxidative Burden and Restenosis: A Case-Control Study
title Association between Oxidative Burden and Restenosis: A Case-Control Study
title_full Association between Oxidative Burden and Restenosis: A Case-Control Study
title_fullStr Association between Oxidative Burden and Restenosis: A Case-Control Study
title_full_unstemmed Association between Oxidative Burden and Restenosis: A Case-Control Study
title_short Association between Oxidative Burden and Restenosis: A Case-Control Study
title_sort association between oxidative burden and restenosis: a case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256427/
https://www.ncbi.nlm.nih.gov/pubmed/35799893
http://dx.doi.org/10.1155/2022/3577761
work_keys_str_mv AT ganjalishiva associationbetweenoxidativeburdenandrestenosisacasecontrolstudy
AT mansouriatena associationbetweenoxidativeburdenandrestenosisacasecontrolstudy
AT abbasifardmitra associationbetweenoxidativeburdenandrestenosisacasecontrolstudy
AT moallemseyedadel associationbetweenoxidativeburdenandrestenosisacasecontrolstudy
AT tayaraninajaranzahra associationbetweenoxidativeburdenandrestenosisacasecontrolstudy
AT sahebkaramirhossein associationbetweenoxidativeburdenandrestenosisacasecontrolstudy